Tubulis Closes €60 Million Series B Financing To Accelerate Its Adc Pipeline And Expand Its Breadth Of Platform Technologies
Amount Raised
€60 Million
Round Type
Series B
MunichBiotechnologyHealth CareDescription
Tubulis today announced the successful completion of a €60 million (USD $63 million) Series B financing led by Andera Partners with participation from new investors Evotec and Fund+. All existing investors also participated in the round, including Bayern Kapital (with Wachstumsfonds Bayern 2), BioMedPartners, coparion, High-Tech Gründerfonds (HTGF), OCCIDENT and Seventure Partners. The new capital will be used to advance Tubulis’ proprietary pipeline of uniquely assembled antibody drug conjugates (ADCs), towards clinical evaluation as well as introduce programs addressing a range of solid tumor indications. The proceeds will enable the company to deliver the true therapeutic potential of ADCs through further innovation of novel payload classes and identification of new cancer targets.
Quick answer
Tubulis raised €60 Million in a Series B round, dated May 3, 2022. Tubulis is based in Munich, Bavaria, Germany.
- How much did Tubulis raise?
- Tubulis raised €60 Million in a Series B round on May 3, 2022.
- What does Tubulis do?
- Tubulis® generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology.
- Where is Tubulis based and how big is it?
- Tubulis is based in Munich, Bavaria, Germany. Fundz records about 73 employees.
- Who are the decision-makers at Tubulis?
- Fundz holds 1 contact at Tubulis. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Tubulis that raised within 45 days of this round, from Fundz verified event records.
- Akero Therapeutics raised an undisclosed amount (Funding Round) on June 16, 2022.
- Ordaos raised $11M on June 15, 2022.
- Mydecine Innovations Group raised $628K (Seed) on June 15, 2022.
- Sling Therapeutics raised $35M (Series A) on June 13, 2022.
- RYNE Biotechnology raised $3M (Seed) on June 13, 2022.
- Gameto raised $9.6M on June 10, 2022.
Who to call at Tubulis, and when
A new round usually means Tubulis is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Tubulis raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Tubulis, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Tubulis. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Tubulis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansTubulis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.